BUSINESS: Karolinska Developments Portfoljbolag AnaCardio Starker Organisationen Infor Klinisk Studie Av Lakemedelskandidaten AC01 I Patienter Med Hjartsvikt
| | | | | | | | | |

BUSINESS: Karolinska Developments Portfoljbolag AnaCardio Starker Organisationen Infor Klinisk Studie Av Lakemedelskandidaten AC01 I Patienter Med Hjartsvikt

STOCKHOLM, SVERIGE 25 oktober 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget AnaCardio har stärkt sin organisation inför initieringen av en fas 1b/2a-studie av läkemedelskandidaten AC01 i patienter med hjärtsvikt. Bolagets mål är att utveckla ett oralt tillgängligt läkemedel som till skillnad från dagens behandlingar kan påverka den underliggande orskaken till sjukdomen.…

BUSINESS: Karolinska Development’s Portfolio Company AnaCardio Strengthens Its Organization To Facilitate Clinical Trial Of The Drug Candidate AC01 In Heart Failure
| | | | | | | | | | | | | | | | |

BUSINESS: Karolinska Development’s Portfolio Company AnaCardio Strengthens Its Organization To Facilitate Clinical Trial Of The Drug Candidate AC01 In Heart Failure

STOCKHOLM SWEDEN – October 25, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the portfolio company AnaCardio has strengthened its organization in preparation for the initiation of a phase 1b/2a study of its drug candidate AC01 in patients with heart failure. The company’s goal is to develop an orally available drug that, unlike…

RESEARCH: Risk Of Stroke Increases With Insulin Resistance, Study Suggests
| | |

RESEARCH: Risk Of Stroke Increases With Insulin Resistance, Study Suggests

Newswise — A study of more than 100,000 people with type 2 diabetes (T2D), presented at the annual meeting of the European Association for the Study of Diabetes (EASD), held online this year, found that insulin resistance is associated with stroke.The higher the insulin resistance, the greater the risk of stroke, the research, from Dr…

End of content

End of content